Source:http://linkedlifedata.com/resource/pubmed/id/17137819
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2007-4-9
|
pubmed:abstractText |
Technological progress and numerous published studies allow to estimate the best place of the 18F-fluorodeoxyglucose positron emission tomography, a real functional metabolic imagery, in the clinical and therapeutic strategy of non small cell lung cancers.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1278-3218
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16-22
|
pubmed:meshHeading |
pubmed-meshheading:17137819-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17137819-Fluorodeoxyglucose F18,
pubmed-meshheading:17137819-Humans,
pubmed-meshheading:17137819-Lung Neoplasms,
pubmed-meshheading:17137819-Neoplasm Staging,
pubmed-meshheading:17137819-Patient Care Planning,
pubmed-meshheading:17137819-Positron-Emission Tomography,
pubmed-meshheading:17137819-Radiopharmaceuticals
|
pubmed:articleTitle |
[Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].
|
pubmed:affiliation |
Service des maladies respiratoires, hôpital d'instruction des armées Percy, 101, avenue Henri-Barbusse, 92141 Clamart, France. vaylet.fabien@gmail.com
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|